Importer of Controlled Substances Application: Sigma-Aldrich International GMBH-Sigma Aldrich Company LLC, 63223-63224 [2016-22076]
Download as PDF
<![CDATA[
63223
Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June
30, 2016, AMPAC Fine Chemicals LLC,
Highway 50 and Hazel Avenue,
Building 05001, Rancho Cordova,
California 95670 applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Schedule
Methylphenidate (1724) ................
Levorphanol (9220) ......................
Thebaine (9333) ...........................
Tapentadol (9780) ........................
II
II
II
II
The company plans to manufacturer
the listed controlled substances in bulk
for distribution to its customers.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–22078 Filed 9–13–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sigma-Aldrich
International GMBH-Sigma Aldrich
Company LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before October 14, 2016. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
October 14, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
DATES:
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on January
19, 2016, Sigma-Aldrich International
GMBH, Sigma Aldrich Co. LLC, 3500
Dekalb Street, Saint Louis, Missouri
63118 applied to be registered as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone (1248) ......................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) I.
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) (7535) .......................................................................................................................................
Butylone (7541) ...........................................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
VerDate Sep<11>2014
20:55 Sep 13, 2016
Jkt 238001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
14SEN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
63224
Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices
Controlled substance
Schedule
Normorphine (9313) ....................................................................................................................................................................................
Etonitazene (9624) ......................................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Glutethimide (2550) .....................................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Opium, powdered (9639) .............................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis.
In reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to import a synthetic
cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–22076 Filed 9–13–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0042]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection;
National Clandestine Laboratory
Seizure Report
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration, will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
November 14, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:55 Sep 13, 2016
Jkt 238001
instrument with instructions or
additional information, please contact
Catherine J. Cmiel-Acevido, Lead IT
Specialist, or Jesus Oswaldo ‘‘Waldo’’
Contreras, IT Specialist, El Paso
Intelligence Center, Drug Enforcement
Administration, 11339 SSG Sims Blvd.,
El Paso, TX 79918.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information Collection
1 Type of Information Collection:
Extension of a currently approved
collection.
2 The Title of the Form/Collection:
National Clandestine Laboratory Seizure
Report.
3 The agency form number, if any,
and the applicable component of the
PO 00000
Frm 00059
Fmt 4703
Sfmt 9990
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Department sponsoring the collection:
EPIC–143.
4 Affected public who will be asked
or required to respond, as well as a brief
abstract: State, Local or Tribal
government law enforcement agencies.
Records reported in the National
Seizure System include clandestine
laboratory seizure information managed
by the El Paso Intelligence Center, Drug
Enforcement Administration, and
available to other law enforcement
agencies in the discharge of their law
enforcement duties and responsibilities.
5 An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that
approximately 7930 respondents will
complete the survey within
approximately one hour.
6 An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 7930
hours. It is estimated that respondents
will take one hour to complete the
survey. In order to calculate the public
burden for the survey, EPIC multiplied
one hour by 7930 which equals 7930
total annual burden hours.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405B,
Washington, DC 20530.
Dated: September 8, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–22012 Filed 9–13–16; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 81, Number 178 (Wednesday, September 14, 2016)]
[Notices]
[Pages 63223-63224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22076]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Sigma-Aldrich
International GMBH-Sigma Aldrich Company LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before October 14, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before October 14, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/ODW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co.
LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be
registered as an importer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
Mephedrone (4-Methyl-N-methylcathinone I
(1248).
N-Ethylamphetamine (1475)................... I
Aminorex (1585)............................. I
Gamma Hydroxybutyric Acid (2010)............ I
Methaqualone (2565)......................... I
Alpha-ethyltryptamine (7249)................ I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395) I..
2,5-Dimethoxyamphetamine (7396)............. I
3,4-Methylenedioxyamphetamine (7400)........ I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
N-Benzylpiperazine (7493)................... I
MDPV (3,4-Methylenedioxypyrovalerone) (7535) I
Butylone (7541)............................. I
Heroin (9200)............................... I
[[Page 63224]]
Normorphine (9313).......................... I
Etonitazene (9624).......................... I
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Glutethimide (2550)......................... II
Nabilone (7379)............................. II
Phencyclidine (7471)........................ II
Diphenoxylate (9170)........................ II
Ecgonine (9180)............................. II
Ethylmorphine (9190)........................ II
Levorphanol (9220).......................... II
Meperidine (9230)........................... II
Thebaine (9333)............................. II
Opium, powdered (9639)...................... II
Levo-alphacetylmethadol (9648).............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis.
In reference to drug codes 7360 (marihuana) and 7370 (THC), the
company plans to import a synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity for these drug codes is
authorized for this registration.
Dated: September 7, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-22076 Filed 9-13-16; 8:45 am]
BILLING CODE 4410-09-P
